Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism CDC42 inhibitors(Cell division control protein 42 homolog inhibitors), RAC1 inhibitors(Rac family small GTPase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | PR | 08 Apr 2024 |